Lamictal 200 mg Tabletten (kaubar/suspendierbar)

Recall | Medicines | 30/11/2023

The marketing authorisation holder informed its customers on Nov 29, 2023 that the tablets cannot be removed as intended due to the label applied to the blister. For this reason, the mentioned batches are being recalled as a precautionary measure.

Name of the medicinal product Lamictal 200 mg Tabletten (kaubar/suspendierbar)
Marketing authorisation number(s) 1-20216-P3
CIP code 4963439
Marketing authorisation holder EurimPharm Vertriebs-GmbH & Co KG
Batch number(s) Batch, Expiry Date
72PJ, 30.09.2025
7VC5, 28.02.2026
Classification of the recall2
Depth of recall Pharmacies
BASG reference number INS-640.001-4552

Further inquiry note